Novartis' FCA Suit Discovery Request Slammed By States
California, New York, New Jersey and eight other states on Monday challenged Novartis Pharmaceutical Corp.'s bid for information on their medication adherence programs, saying the information is irrelevant to a whistleblower...To view the full article, register now.
Already a subscriber? Click here to view full article